Perrigo (PRGO) Non-Current Deferred Tax Liability (2013 - 2026)

Perrigo's (PRGO) quarterly Non-Current Deferred Tax Liability came in at $153.5 million in Q1 2026, down 18.87% year-on-year from $189.2 million in Q1 2025, and down 9.12% on a QoQ basis from $168.9 million in Q4 2025.

Perrigo (PRGO) Non-Current Deferred Tax Liability (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Non-Current Deferred Tax Liability data on file, last reported at $153.5 million in Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 18.87% year-over-year to $153.5 million in Q1 2026; TTM through Mar 2026 was $153.5 million, a 18.87% decrease from a year earlier, with the FY2025 full-year figure at $168.9 million, down 16.88% from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2026 stood at $153.5 million, down from $168.9 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for PRGO reached as high as $409.1 million in Q4 2022 and fell as low as $153.5 million in Q1 2026.
  • Historically, Non-Current Deferred Tax Liability has averaged $264.0 million across 5 years, with a median of $238.9 million in 2022.
  • Across the five-year window, Non-Current Deferred Tax Liability surged 68.35% in 2022 and tumbled 38.81% in 2024, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at $368.2 million in 2022, then declined by 28.76% to $262.3 million in 2023, then decreased by 22.53% to $203.2 million in 2024, then dropped by 16.88% to $168.9 million in 2025, then decreased by 9.12% to $153.5 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $153.5 million in Q1 2026, $168.9 million in Q4 2025, and $194.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 153.50 Mn
Mar 28, 2026 153.50 Mn
Dec 31, 2025 168.90 Mn
Dec 31, 2025 168.90 Mn
Sep 27, 2025 194.40 Mn
Sep 27, 2025 194.40 Mn
Jun 28, 2025 206.80 Mn
Jun 28, 2025 206.80 Mn
Mar 29, 2025 189.20 Mn
Mar 29, 2025 189.20 Mn
Dec 31, 2024 203.20 Mn
Dec 31, 2024 203.20 Mn
Sep 28, 2024 213.80 Mn
Sep 28, 2024 213.80 Mn
Jun 29, 2024 211.70 Mn
Jun 29, 2024 211.70 Mn
Mar 30, 2024 247.70 Mn
Mar 30, 2024 247.70 Mn
Dec 31, 2023 262.30 Mn
Dec 31, 2023 262.30 Mn